Incidence rates of soft tissue sarcoma among U.S. military servicemen: Comparison with the rates in the general U.S. population
Cancer · 2025
DOI: 10.1002/cncr.35607 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer, 2025. Verfasst von Julie A Bytnar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Military Personnel, Sarcoma, SEER Program. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Soft tissue sarcoma (STS) is one of the most frequently diagnosed cancers among men younger than age 30 years and a leading cause of cancer death in men younger than age 40 years. The military may be more exposed to STS risk factors and have generally better health and health care access than the general population, which may relate to lower cancer risk and/or early detection. This study compared STS incidence between servicemen and men in the general U.S. population.
Methods
Data were from the Department of Defense’s Automated Central Tumor Registry (ACTUR) and the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program. Subjects were active‐duty servicemen in ACTUR and men in SEER aged 18–59 years diagnosed with STS from 1990 to 2013. Age‐adjusted rates, incidence rate ratios (IRR), and 95% CIs were calculated.
Results
STS incidence rates were lower in ACTUR than SEER overall (IRR = 0.86 [0.78‐0.93]), for 18‐ to 39‐year‐old men (IRR = 0.78 [0.70‐0.86]), by race (White: IRR = 0.85 [0.77‐0.95]; Black: IRR = 0.77 [0.63‐0.94]), for sites other than skin/connective/soft tissue (IRR = 0.49 [0.37‐0.63]), other specified histologies (IRR = 0.84 [0.71‐0.98]), and unspecified histology (IRR = 0.57 [0.38‐0.82]). Rates were lower in ACTUR for regional (IRR = 0.37 [0.28‐0.47]) and distant metastases (IRR = 0.58 [0.43‐0.76]), even when race and age stratified. However, rates were higher in ACTUR for 40‐ to 59‐year‐old men (IRR = 1.25 [1.04‐1.48]) and localized tumors (IRR = 1.16 [1.04‐1.29]).
Conclusion
Lower STS rates among servicemen may relate to better health and early detection and treatment of STS‐associated conditions within the military health system, which provides universal care. Higher rates among 40‐ to 59‐year‐old servicemen may result from greater cumulative military‐related exposures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
- The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
- John P. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
- Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
ORCID-Profile: Julie A Bytnar, Ashley B Anderson
Zitieren
APA
Bytnar, J. A., Anderson, A. B., Potter, B. K., Shriver, C. D., & Zhu, K. (2025). Incidence rates of soft tissue sarcoma among U.S. military servicemen: Comparison with the rates in the general U.S. population. Cancer. https://doi.org/10.1002/cncr.35607
Vancouver
Bytnar JA, Anderson AB, Potter BK, Shriver CD, Zhu K. Incidence rates of soft tissue sarcoma among U.S. military servicemen: Comparison with the rates in the general U.S. population. Cancer. 2025. doi:10.1002/cncr.35607
BibTeX
@article{Bytnar2025,
author = {Bytnar, Julie A and Anderson, Ashley B and Potter, Benjamin K and Shriver, Craig D and Zhu, Kangmin},
title = {Incidence rates of soft tissue sarcoma among U.S. military servicemen: Comparison with the rates in the general U.S. population},
journal = {Cancer},
year = {2025},
doi = {10.1002/cncr.35607}
}
EUVIMED